Vaccine-mediated treatment of neurological disorders
CA 2361124 A1 · Owner: Auckland Technology Enabling Corporation Limited · Inventors: During, Matthew John
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method of treating or preventing development of a neurological disorder has been developed wherein a subject with the disorder or, at risk of developing a disorder, is vaccinated against a brain protein or antigen. Alternatively, the antibodies can be directly administered to the individual in need of treatment thereof. Animal studies demonstrate potent efficacy in the treatment of epilepsy stroke and cognition, in animal models vaccinated against the NMDA receptor.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 24, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 24, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 24, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.